Core Insights - Noble Mineral Exploration Inc. announced the initial mineral resource estimate for the Mann West Nickel Sulphide Project, a joint venture with Canada Nickel Company, located in the Timmins area of Northern Ontario [1][2][4] Company Overview - Noble holds a 20% interest in East Timmins Nickel Ltd., which owns the Mann West project, while Canada Nickel holds the remaining 80% [2][3] - Noble Mineral Exploration has extensive mineral rights in Northern Ontario and other regions, focusing on nickel, cobalt, and base metals [29][30] Project Details - The Mann West project is located 21 kilometers east of Canada Nickel's Crawford Nickel Sulphide Project and has a geophysical target area of 3.4 square kilometers, more than double that of Crawford [3][4] - The initial mineral resource estimate includes 406 million tonnes of indicated resources grading 0.23% nickel and 599 million tonnes of inferred resources grading 0.22% nickel, totaling 0.95 million tonnes and 1.31 million tonnes of contained nickel, respectively [5][8] - An exploration target of an additional 0.5 to 1.0 billion tonnes grading between 0.20% and 0.22% nickel is anticipated, pending further drilling [5][8] Resource Estimates - The Mann West project has a significant PGM zone with indicated resources of 7.0 million tonnes grading 0.422 g/t palladium and platinum, and inferred resources of 7.7 million tonnes grading 0.411 g/t [5][8] - The resource dimensions are approximately 1.9 kilometers long, 800 meters wide, and extend to 500 meters deep, remaining open to the northwest and at depth [5][8] Future Plans - Canada Nickel plans to announce additional mineral resources, with expectations for eight new resources by the end of 2025, including two more this month [4][8] - Noble aims to increase and upgrade inferred resources through ongoing drilling campaigns and mineralogical analysis [28]

Core Insights - Lexaria Bioscience Corp. has successfully completed a human study comparing oral DehydraTECH-liraglutide to injected Saxenda®-branded liraglutide, with partial results now available [1][8] - The study demonstrated a 22.7% reduction in adverse events (AEs) for oral DehydraTECH-liraglutide compared to Saxenda®, with significant reductions in nausea (67%) and gastrointestinal AEs (31%) [3][4] - Lexaria is seeking a pharmaceutical partner to develop an FDA-registered oral alternative to current injectable GLP-1 drugs, addressing an unmet market need [2][10] Study Details - The study involved 10 overweight volunteers, comparing daily doses of Saxenda® (0.6 mg) and DehydraTECH-liraglutide (45 mg) over a 7-day period [13] - The primary endpoint was the evaluation of safety and tolerability, with secondary objectives including pharmacokinetics and effects on body weight, blood glucose, and insulin levels [16] - Weight loss was observed in 9 out of 10 participants in both study arms, although it was not the primary goal of the study [5] Technology and Market Context - DehydraTECH is a patented drug delivery technology that enhances bio-absorption and reduces side effects, with 48 patents granted and more pending [17] - The study's results suggest that DehydraTECH-liraglutide could provide a viable oral alternative to Saxenda® and other injectable liraglutide products, which generated significant revenue for Novo Nordisk [12] - Lexaria's approach may allow for an expedited FDA regulatory pathway under the 505(b)(2) application, contingent on demonstrating comparable performance to existing injectable versions [6][10]

Core Points - Herbal Dispatch Inc. has adjourned its 2024 and 2025 Annual General and Special Shareholder Meeting originally scheduled for June 10, 2025, to June 17, 2025 [1] - The adjourned meeting will be held virtually via Zoom and physically at a specified location in Vancouver, B.C. [1] - The company was unable to meet its proxy requirements for the former meeting, necessitating the adjournment [2] - All proxies submitted for the former meeting will remain valid for the adjourned meeting unless revoked or amended [3] Company Overview - Herbal Dispatch Inc. operates leading cannabis e-commerce platforms and aims to provide high-quality cannabis products at affordable prices [6] - The company's flagship marketplace, herbaldispatch.com, offers exclusive access to small-batch craft cannabis flower and various other product formats [6] - Herbal Dispatch's common shares are traded on the Canadian Securities Exchange under the symbol "HERB" [6]

Core Insights - Quantum Critical Metals Corp. is exploring a poly-metallic play at its NMX East project in Quebec, which includes gallium, rubidium, and cesium [1][2] - The company has discovered significant mineralization, including 107.69 meters of 38.85 gpt gallium, 701 gpt rubidium, 24.98 gpt cesium, and 3.61 gpt thallium from surface drilling [2] - Quantum is investigating the Bande du Lac des Montagnes rock formation, known for hosting platinum group elements, which could enhance the project's mineral potential [2][4] Project Developments - The NMX East project is strategically located near the NISK shear zone and is less than 100 meters from the Bande du Lac des Montagnes outcrop [4] - Power Metallic Mines Ltd. has expanded its project area by over 300% by acquiring 167 km² from Li-FT Power, which includes claims adjacent to Quantum's NMX East property [5] - CEO Marcy Kiesman highlighted that this adjacency to a rapidly expanding polymetallic district enhances the strategic value of the NMX East project [5] Future Plans - The company plans to conduct field reconnaissance to assess the presence of Bande du Lac des Montagnes outcrops on the NMX East property [7] - Quantum intends to collaborate with geophysics companies to explore the potential for PGE mineralization beneath the surface [7] Company Overview - Quantum Critical Metals Corp. focuses on advancing critical metals projects, including the NMX East Gallium-Rubidium-Cesium Project and several other projects in British Columbia [9] - The company is positioned to support the transition to a secure and sustainable critical minerals supply in the West [9]

Core Viewpoint - Fitzroy Minerals Inc. has reported significant drilling results from the Buen Retiro Copper Project, indicating a large-scale and high-grade copper mineralization system, particularly highlighted by drill hole BRT-DDH022 which returned 110 m @ 1.94% Cu [1][2][5]. Exploration and Drilling Results - The ongoing drilling program at Buen Retiro has confirmed the presence of high-grade copper mineralization, with BRT-DDH022 intersecting 110 m @ 1.94% Cu and 416 ppm Co, including 58 m @ 3.06% Cu from 97 m [5][8]. - Historical drill holes in the Southwest Area have shown a trend with several hundred meters of strike length, returning intersections with grades over 1% copper [2][15]. - The project covers an area of 13,240 hectares and is strategically located near significant infrastructure, facilitating rapid development [3][30]. Future Exploration Plans - The company plans to drill at least 8,000 m in 2025, focusing on the Southwest and North areas, with potential use of a Reverse Circulation (RC) drill rig to accelerate exploration [7][23]. - Exploration efforts will target near-surface copper mineralization within a 1 km-wide by 4 km-long corridor, with ongoing assessments of deeper mineralization potential [3][23]. Geological Insights - The geology of BRT-DDH022 is characterized by typical Iron-Oxide Copper Gold (IOCG) style, with significant hydrothermal alteration and the presence of high-grade copper minerals [10][15]. - The mineralization in the Southwest Area is interpreted to be associated with a sub-vertical structure, enhancing the depth potential for copper [15][16]. Assay Results and Quality Control - Assay results from the ongoing drilling have shown promising intersections, with the best results from BRT-DDH022 indicating a maximum of 12.86% Cu over a 1.0 m sample [10][8]. - The company employs rigorous QA/QC procedures, including the use of certified standards and blanks to ensure the accuracy of laboratory analyses [24][26].

Group 1: Election of Directors - All six nominees listed in the Management Proxy Circular were elected as directors for the upcoming year, with Marc-Antoine Audet receiving 97.20% of votes in favor, and Quentin Markin and Terry Krepiakevich receiving 100% [2][3] - A total of 72,717,248 common shares, representing 33.04% of the Company's issued and outstanding shares, were represented at the AGM [1][3] Group 2: Appointment of Auditors - Pricewaterhouse Coopers LLP was approved as the External Auditors for the Company for the next year, with the Directors authorized to fix their remuneration [2] Group 3: Stock Option Plan - The shareholders approved the Corporation's Stock Option Plan, reserving the grant of options up to a maximum of 10% of the total number of issued and outstanding shares, with 97.63% voting in favor [3] Group 4: Company Overview - Sama Resources Inc. is a Canadian-based resource company focused on the Samapleu nickel-copper project in Côte d'Ivoire, with a 40% interest in the project, while Ivanhoe Electric holds the remaining 60% [6] - The Company is transitioning from the basic OTC Pink Sheets to the enhanced OTC ID designation effective July 1, 2025, which will improve transparency and market presence [7]

Core Viewpoint - Panther Minerals Inc. has successfully completed a debt settlement agreement to address outstanding debts totaling CAD $14,785.71, enhancing its cash position for working capital purposes [1][2]. Group 1: Debt Settlement Details - The company issued 924,106 common shares at a deemed price of CAD $0.016 per share as part of the debt settlement [1]. - The shares issued are subject to a hold period of four months and one day, in accordance with National Instrument 45-105 – Prospectus Exemptions [1]. Group 2: Company Overview - Panther Minerals is engaged in mineral exploration, focusing on its North American project portfolio [3]. - The acquisition of the Boulder Creek option demonstrates the company's commitment to pursuing advanced and high-quality uranium projects that can be efficiently explored [3].

Core Viewpoint - Fitzroy Minerals Inc. has reported significant drilling results from the Buen Retiro Copper Project, indicating a large-scale and high-grade copper mineralization system, particularly highlighted by drill hole BRT-DDH022 which returned 110 m @ 1.94% Cu [1][2][5] Exploration and Drilling Results - The ongoing drilling program at Buen Retiro has confirmed the presence of high-grade copper mineralization, with BRT-DDH022 intersecting 110 m @ 1.94% Cu and 416 ppm Co, including 58 m @ 3.06% Cu from 97 m [5][8] - The project area covers 13,240 hectares and is located 57 km southwest of Copiapó, Chile, with a focus on near-surface copper mineralization within a 1 km-wide by 4 km-long corridor [1][3] - Phase 1 drilling was completed prior to the acquisition of Ptolemy Mining Ltd, with results documented in a technical report filed on November 8, 2024 [3] Future Plans - The company aims to drill at least 8,000 m in 2025, with a focus on the Southwest and North areas, and is considering switching to a Reverse Circulation drill rig to accelerate exploration [7][24] - Exploration efforts will continue to delineate extensions of mineralization along strike and at depth, particularly in the Southwest Area [24] Mineralization Characteristics - The mineralization in BRT-DDH022 is characterized by leachable green copper oxides, including tenorite, cuprite, and chalcocite, with significant hydrothermal alteration observed [5][10] - The presence of high-grade cuprite and chalcocite feeder structures enhances the depth potential of copper mineralization at Buen Retiro [2][15] Assay Results - The best assay results to date from the project are from hole BRT-DDH022, which intersected 110 m @ 1.94% Cu and 416 ppm Co, indicating a strong mineralization trend [8][12] - Other drill holes in the Southwest Area have shown promising intersections averaging between 0.5% to 1.9% Cu in oxides and leachable minerals from surface [15][21] Geological Context - The geology of BRT-DDH022 is described as typical of Iron-Oxide Copper Gold (IOCG) style, with significant brecciation and alteration, indicating a robust mineralizing system [10][15] - The mineralization is interpreted to be associated with a sub-vertical structure located near the center of a major magnetic anomaly [15][16]

Company Announcement - MAX Power Mining Corp. has appointed Mr. Ryan Cheung as Chief Financial Officer effective May 20, 2025, bringing extensive experience in financial oversight to the company [1] - Mr. Byran Loree has resigned as Chief Financial Officer and Director, with appreciation expressed for his contributions since the company's inception in 2021 [3] Leadership Background - Mr. Cheung is a CPA, CA, and the founder of MCPA Services Inc., with a background in auditing junior mining and resource companies, and has been an active member of the Institute of Chartered Professional Accountants of British Columbia since January 2008 [2] Company Focus - MAX Power is focused on mineral exploration, particularly in the context of North America's shift to decarbonization, and is a first mover in the Natural Hydrogen sector [4] - The company has strategic alliances with Chapman Hydrogen & Petroleum Engineering Ltd. and Larin Engineering HHC, and holds properties in the U.S. and Canada, including a notable discovery at the Willcox Playa Lithium Project in Arizona [4]

Core Insights - Lexaria Bioscience Corp. will participate in the BIO International Convention in Boston from June 16-19, 2025, aiming to advance discussions with potential partners and investors [1][2] Company Overview - Lexaria is a global innovator in drug delivery platforms, specifically through its patented DehydraTECH® technology, which enhances drug absorption and reduces side effects [4] - The company holds 48 granted patents and has additional patents pending worldwide, showcasing a strong intellectual property portfolio [4] Event Participation - The BIO International Convention is the largest biotechnology convention globally, featuring over 1,500 exhibitors and 20,000 attendees, providing a platform for networking and collaboration [2] - Lexaria is arranging one-on-one meetings with corporate leaders in sectors such as weight loss, diabetes, and hypertension, with limited meeting slots still available [3]